Anúncio
Anúncio
ATRA
Atara Biotherapeutics, Inc
13.79
USDPatrocinado
-3.65
-20.94%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
13.69
-0.10
-0.71%
Relatórios de Lucros ATRA
Rácio de surpresa positiva
ATRA separação 19 de 40 últimas estimativas.
48%
Próximo Relatório
Data do Próximo Relatório
05 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$2.72M
/-$0.44
Mudanças implicadas de Q3 25 (Revenue/ EPS)
-21.09%
/+37.50%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-91.68%
/-63.03%
Atara Biotherapeutics, Inc earnings per share and revenue
On 12 de nov. de 2025, ATRA reported earnings of -0.32 USD per share (EPS) for Q3 25, beating the estimate of -0.87 USD, resulting in a 63.52% surprise. Revenue reached 3.45 milhão, compared to an expected 1.43 milhão, with a 142.21% difference. The market reacted with a -0.72% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analistas forecast an EPS of -0.44 USD, with revenue projected to reach 2.72 milhão USD, implying an aumentar of 37.50% EPS, and diminuir of -21.09% in Revenue from the last quarter.
FAQ
What were Atara Biotherapeutics, Inc's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Atara Biotherapeutics, Inc reported EPS of -$0.32, beating estimates by 63.52%, and revenue of $3.45M, 142.21% above expectations.
How did the market react to Atara Biotherapeutics, Inc's Q3 2025 earnings?
The stock price moved down -0.72%, changed from $12.56 before the earnings release to $12.47 the day after.
When is Atara Biotherapeutics, Inc expected to report next?
The next earning report is scheduled for 05 de mar. de 2026.
What are the forecasts for Atara Biotherapeutics, Inc's next earnings report?
Based on 6
analistas, Atara Biotherapeutics, Inc is expected to report EPS of -$0.44 and revenue of $2.72M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio